The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment

The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment

Abstract Background Clinical high risk for psychosis (CHR) is often managed with antipsychotic medications, but their effects on neurocognitive performance and clinical outcomes remain insufficiently explored. This study investigates the association between aripiprazole and olanzapine use and cogn...

Full description

Saved in:
Bibliographic Details
Main Authors: JiaHui Zeng, Andrea Raballo, JiaYi Ye, YuQing Gao, WenJun Su, YanYan Wei, XiaoChen Tang, LiHua Xu, YeGang Hu, Dan Zhang, HuiRu Cui, YingYing Tang, XiaoHua Liu, HaiChun Liu, Tao Chen, ChunBo Li, JiJun Wang, TianHong Zhang
Format: Article
Language:English
Published: Cambridge University Press 2025-01-01
Series:European Psychiatry
Subjects:
antipsychotics
aripiprazole
clinical high risk for psychosis (CHR)
cognitive performance
olanzapine
Online Access:https://www.cambridge.org/core/product/identifier/S0924933825024599/type/journal_article
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cambridge.org/core/product/identifier/S0924933825024599/type/journal_article

Similar Items